Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push

cafead

Administrator
Staff member
  • cafead   Aug 22, 2024 at 12:02: PM
via Eli Lilly has expanded its partnership with Oblique Therapeutics, adding a second strand to an alliance focused on using the AbiProt platform to discover antibodies against high-value targets.

article source
 

<